| Filed On | Filing |
|---|---|
| 02 Oct 2026 |
Form 4: Wright Timothy, Director
Granted 1,178.764 Deferred Stock Units |
| 02 Oct 2026 |
Form 4: Harrison Thomas L, Director
Received 4,443 shares as a grant or award ($30.6K) |
| 16 Sep 2026 |
Form 4: Marcucci Marco Tullio, Director
Granted 7,500 Stock Option |
| 15 Sep 2026 |
Form 3: Marcucci Marco Tullio, Director
Holds 4,480 shares of Common Stock |
| 11 Sep 2026 | S-3 |
| 02 Sep 2026 | S-8 |
| 18 Aug 2026 | 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more |
| 17 Aug 2026 | 424B3 |
| 14 Aug 2026 | EFFECT |
| 13 Aug 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 12 Aug 2026 |
Form 4: Armen Garo H, Director
Granted 1,971,500 Stock Option |
| 11 Aug 2026 |
Form 4: Harrison Thomas L, Director
Granted 50,000 Stock Option |
| 11 Aug 2026 |
Form 4: Corvese Brian, Director
Granted 100,000 Stock Option |
| 11 Aug 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 07 Aug 2026 | 10-Q |
| 07 Aug 2026 |
Form 4: Wright Timothy, Director
Granted 50,000 Stock Option |
| 07 Aug 2026 |
Form 4: O'Day Steven J, Chief Medical Officer
Granted 100,000 Stock Option |
| 07 Aug 2026 |
Form 4: Hirsch Susan B, Director
Granted 50,000 Stock Option |
| 07 Aug 2026 |
Form 4: Buell Jennifer, Director
Granted 200,000 Stock Option |
| 07 Aug 2026 | S-3 |
Loading...